Century Therapeutics Insider Sale: SVP Carr Douglas Triggers Tax‑Withheld Sale, Holds Steady 515K Shares Amid Volatile Biotech Stock 【news flash】
Insider sale alert: Carr Douglas sells 323 shares of Century Therapeutics for $1.82—tax‑triggered, not a profit‑seeking move, yet signals long‑term confidence amid market volatility and a recent $135 million private placement.
3 minutes to read